No Data
STEMCELL Launches Novel Cell-Engineering CellPore Transfection System
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
STEMCELL Technologies Announces Successful Asset Purchase Agreement With SQZ Biotechnologies Company
SQZ Biotechnologies GAAP EPS of -$0.80 Misses by $0.30, Revenue of $0M
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates
SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting
No Data
placid Raccoon_7562 : me too
alpha68 : Run! Run!